WallStreetZenWallStreetZen

NASDAQ: BBIO
Bridgebio Pharma Inc Earnings & Revenue

BBIO past revenue growth

How has BBIO's revenue growth performed historically?
Company
-88.02%
Industry
154.55%
Market
17.87%
BBIO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
BBIO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

BBIO earnings and revenue history

Current Revenue
$9.3M
Current Earnings
-$643.2M
Current Profit Margin
-6,913.9%

BBIO Return on Equity

Current Company
N/A
Current Industry
-63.5%
Current Market
188%

Be the first to know when BBIO announces earnings.

BBIO Return on Assets

Current Company
-110.4%
Current Industry
2.9%
BBIO is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

BBIO Return on Capital Employed

Current Company
-139.59%
Current Industry
19.5%
BBIO's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BBIO vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
BBIO$9.30M-$551.39M-$643.20M-30.80%N/A
MDGL$0.00-$360.39M-$373.63MN/AN/A
IMVT$0.00-$242.72M-$243.45MN/AN/A
CRSP$371.21M-$130.89M-$153.61M+160.00%N/A
KRYS$50.70M$17.90M$10.93MN/AN/A

BBIO earnings dates

Next earnings date
May 2, 2024

Bridgebio Pharma Earnings & Revenue FAQ

What were BBIO's earnings last quarter?

On Invalid Date, Bridgebio Pharma (NASDAQ: BBIO) reported Q4 2023 earnings per share (EPS) of -$0.96, up 4.35% year over year. Total Bridgebio Pharma earnings for the quarter were -$168.15 million. In the same quarter last year, Bridgebio Pharma's earnings per share (EPS) was -$0.92.

If you're new to stock investing, here's how to buy Bridgebio Pharma stock.

What was BBIO's earnings growth in the past year?

As of Q2 2024, Bridgebio Pharma's earnings has grown year over year. Bridgebio Pharma's earnings in the past year totalled -$643.20 million.

What is BBIO's earnings date?

Bridgebio Pharma's earnings date is Invalid Date. Add BBIO to your watchlist to be reminded of BBIO's next earnings announcement.

What was BBIO's revenue last quarter?

On Invalid Date, Bridgebio Pharma (NASDAQ: BBIO) reported Q4 2023 revenue of $1.75 million up 6.68% year over year. In the same quarter last year, Bridgebio Pharma's revenue was $1.87 million.

What was BBIO's revenue growth in the past year?

As of Q2 2024, Bridgebio Pharma's revenue has grown -88.02% year over year. This is 242.57 percentage points lower than the US Biotechnology industry revenue growth rate of 154.55%. Bridgebio Pharma's revenue in the past year totalled $9.30 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.